Market Rank #15 · Evidence Tier A

Sweden
Neuroscience Intelligence

Sweden neuroscience intelligence: 200 indexed trials, 78 institutions, research score 41.62.

⚗
200Indexed trials
↗
43Recruiting
⌂
78Research institutions
◎
41.6Research score

Evidence profile

79Sponsors
26Disease areas
0Institution works
0Institution citations

Evidence signals

Research score 41.6 · Data confidence 100.00 · Evidence 41.6

Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.

Leading disease areas

alzheimers44trials
parkinsons22trials
adhd15trials
stroke14trials
depression12trials
other_neurology10trials
epilepsy10trials
other_psychiatry9trials
multiple_sclerosis8trials
anxiety8trials

Leading indexed sponsors

Karolinska Institutet48trials
Merck Sharp & Dohme LLC8trials
Hoffmann-La Roche8trials
Region Skane6trials
Boehringer Ingelheim6trials
Eli Lilly and Company5trials
Pfizer5trials
Göteborg University5trials
Sahlgrenska University Hospital5trials
Uppsala University5trials